Cargando…

59. Impact of Pharmacist-Led De-Escalation of MRSA Therapy Using MRSA Nasal PCR

BACKGROUND: Experts suggest that a highly sensitive MRSA nasal PCR can be used to rule out MRSA pneumonia with a negative predictive value greater than 95%. At Adventist Health Glendale (AHGL), the MRSA nasal PCR had a 97% negative predictive value. Pharmacist-led de-escalation of MRSA therapy using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvatus, Marc, Jung, Hemi, Eskandarian, Romic, Lee, Su
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643868/ http://dx.doi.org/10.1093/ofid/ofab466.261

Ejemplares similares

1451. Predictive Values of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab PCR Assay for MRSA Pneumonia
por: Chou, Man Ting, et al.
Publicado: (2018)

1215. The Impact of MRSA Nasal PCR on Antibiotic De-escalation
por: Silverman, Adam, et al.
Publicado: (2023)

1489. Safety and Performance of a Pharmacist-Driven Nasal MRSA PCR Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia at an Academic Medical Center
por: Meng, Lina, et al.
Publicado: (2020)

2948. Pediatric Clinical Outcomes of MRSA PCR Utilization for Anti-MRSA De-escalation
por: Demirhan, Salih, et al.
Publicado: (2023)

1994. Impact of Pharmacist-initiated MRSA Nasal PCR Protocol on Pneumonia Therapy in a Community Teaching Hospital
por: Pham, Selena, et al.
Publicado: (2019)

1999. Does Pharmacist-Driven Methicillin-Resistant Staphylococcus aureus PCR Nasal Screening Decrease Time to De-Escalation of MRSA Coverage in Patients with Pneumonia?
por: Waters, Dustin, et al.
Publicado: (2019)

Pharmacist-Driven MRSA Nasal PCR Screening and the Duration of Empirical Vancomycin Therapy for Suspected MRSA Respiratory Tract Infections
por: Woolever, Nathan L., et al.
Publicado: (2020)

2153. Clinical Impact of Addition of Oropharynx MRSA PCR to Anterior Nares MRSA PCR for Patients Admitted with Pneumonia
por: Kessler, Michael, et al.
Publicado: (2019)

79. Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal PCR Assays Beyond Respiratory Infections
por: Noeldner, Haley M, et al.
Publicado: (2021)

2573. The Use of MRSA PCR for De-escalation of Anti-MRSA therapy for CAP and HAP at a Community Hospital: a Quality Improvement Analysis for Antibiotic Stewardship
por: Browne, Angelina M, et al.
Publicado: (2023)

2157. Evaluation of the Utility of the MRSA Nasal PCR Assay in a Community Healthcare System
por: Hobbs, Athena L V, et al.
Publicado: (2019)

1191. The Implementation of Nasal MRSA PCR for Pneumonia and Association with Antibiotic Use and Clinical Outcomes
por: Fenlon, Luke A, et al.
Publicado: (2023)

79. Outcomes Associated with the Utilization of the Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Polymerase Chain Reaction (PCR) Assay to De-escalate Vancomycin Therapy in Patients with Suspected Pneumonia at a Rural Community Hospital
por: Tirupathi, Raghavendra, et al.
Publicado: (2020)

272. Clinical Outcomes with Continuation of Combination Antibiotic Therapy versus De-escalation to Monotherapy for Patients with MRSA Bacteremia
por: Nichols, Courtney, et al.
Publicado: (2020)

Predictive Characteristics of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab for MRSA-positive Culture in Hospitalized Veterans
por: Fox, Teresa, et al.
Publicado: (2017)

Nasal Decolonisation of MRSA
por: Mantle, Peter
Publicado: (2019)

306 Switch from MRSA PCR to Agar for Nasal Screening Does Not Increase Transmission
por: Strymish, Judith, et al.
Publicado: (2014)

116. Leveraging the Use of the PCR-based Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab in the Emergency Department to Optimize Vancomycin Use in the Inpatient Setting
por: McManus, Dayna, et al.
Publicado: (2020)

110. MRSA nasal swab as a stewardship tool to guide IV Vancomycin in diabetic foot infections
por: Lazo-Vasquez, Alex, et al.
Publicado: (2021)

741. Assessing the Concordance of MRSA Carriage Screening with MRSA Infections
por: Mannheim, Jonathan, et al.
Publicado: (2023)

2010. A Significant Reduction in Empiric Vancomycin Days of Therapy for Suspected MRSA Pneumonia in Adult Non-ICU Patients After Implementation of a Rapid MRSA Nasal PCR Test with Antimicrobial Stewardship Intervention
por: Markoski, Nikola, et al.
Publicado: (2019)

1494. Validation of Methicillin-Resistant Staphylococcus aureus (MRSA) Risk Factors in Predicting MRSA Community-Acquired Pneumonia at an Academic Medical Center
por: Arieno, Joelle, et al.
Publicado: (2020)

639 Impact of De-escalating Contact Precautions on MRSA Infection Rates in an Academic Medical Center
por: Edmond, Michael, et al.
Publicado: (2014)

P18 Prevalence and risk factors for nasal colonization with MRSA among children attending immunization in Port Harcourt, Nigeria
por: Oreh, Chinekwu N.
Publicado: (2022)

1266. Refining Antimicrobial Stewardship by De-escalating Vancomycin Using MRSA (Methicillin Resistant Staphylococcus aureus) Nasal Screening in a Community Hospital Setting
por: Shah, Ruta, et al.
Publicado: (2023)

562. Reducing MRSA Bacteremia in Adult Patients through MRSA Decolonization Bundle
por: Goldman, Erin, et al.
Publicado: (2019)

155. Use of MRSA PCR and Antimicrobial Stewardship Intervention to Limit Anti-MRSA Therapy in Respiratory Tract Infections at a Community Teaching Hospital
por: Politis, Paula A, et al.
Publicado: (2023)

1804. Quality Improvement Project to improve empiric antibiotic therapy for skin and soft tissue infections using the nasal MRSA PCR
por: Kasule, Sabirah N, et al.
Publicado: (2022)

MRSA screening in emergency department detects a minority of MRSA carriers
por: Mogensen, Christian B, et al.
Publicado: (2015)

102. Effects of an Antimicrobial Stewardship-guided MRSA Nasal Screening Review on Vancomycin Utilization for Respiratory Infections: A Quasi-Experimental Study
por: Pineda, Ross, et al.
Publicado: (2020)

854. Infection Prevention vs. Antimicrobial Stewardship: Does Nasal Povidone-Iodine Interfere with Methicillin Resistant Staphylococcus aureus (MRSA) Screening?
por: Harrison, Cecelia K, et al.
Publicado: (2020)

P056: The patient experience of the mrsa screening process and the impact of a MRSA positive result: a qualitative study
por: Loveday, H, et al.
Publicado: (2013)

1239. Ceftaroline versus Vancomycin as First-Line Therapy for MRSA Bacteremia
por: Kamath, Meghan, et al.
Publicado: (2021)

153. Sensitivity of MRSA Nasal Screening in Patients with Staphylococcus aureus Pneumonia: Impact of a More Sensitive Comparator
por: Papamanolis, Irene-Constantina, et al.
Publicado: (2023)

MRSA on surface: is it possible to control?
por: Shimura, CN, et al.
Publicado: (2011)

1367. Reduced Ceftaroline Susceptibility Among Invasive MRSA Isolates at a Tertiary Children’s HospitalReduced Ceftaroline Susceptibility Among Invasive MRSA Isolates at a Tertiary Children’s Hospital
por: Sommer, Lauren, et al.
Publicado: (2020)

Control of methicillin-resistant Staphylococcus aureus (MRSA): the impact of active surveillance for MRSA in a non-acute hospital in Madrid (Spain)
por: Bischofberger, C, et al.
Publicado: (2011)

1213. Evaluation of an Alcohol-Based Antiseptic for Nasal Decolonization of Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Kanwar, Anubhav, et al.
Publicado: (2018)

589. Impact of Parents and the Environment on MRSA Transmission in the Neonatal ICU
por: Reich, Patrick J, et al.
Publicado: (2019)

78. Impact of Methicillin-Resistant Staphylococcus aureus (MRSA) Nares Screen on Vancomycin Utilization for Respiratory Tract Infections
por: Debnath, Ashita, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9c4pjun6874hmcn08ocsacd1gf